Virginia Biotechnology group taps Jeffrey Gallagher as CEO
- September 25, 2012
The Virginia Biotechnology Association , a statewide non-profit trade association for life science industries, has named its interim executive director to the full-time position of CEO.
Gallagher will be responsible for developing and executing the association’s strategic plans, prioritizing its areas of advocacy and serving as a voice for the organization and its more than 200 member companies.
“He will serve as an articulate and respected champion for our diverse member companies, particularly at a time when the life sciences throughout Virginia are emerging as an increasingly important growth sector,” Michael Grisham, the association’s chairman of the board, said in a statement.
Gallagher was most recently with Lyotropic Therapeutics Inc., based in Ashland, where he served as vice president and general counsel for the pharmaceutical company. Gallagher also has been involved with numerous non-profit organizations in various leadership roles.
One of the first priorities for Gallagher is to lead the Virginia delegation at the Mid-Atlantic Bio Conference cohosted by Virginia Bio each year. The conference takes place this week in Bethesda, Md.